Rosetta Genomics Ltd.
ROSG
ROSG was delisted on the 21st of May, 2018.
11 hedge funds and large institutions have $1.36M invested in Rosetta Genomics Ltd. in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
1,125% more call options, than puts
Call options by funds: $49K | Put options by funds: $4K
36% more capital invested
Capital invested by funds: $1M → $1.36M (+$363K)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$494K |
| 2 |
HCM
Highlander Capital Management
Short Hills,
New Jersey
|
+$422K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$286K |
| 4 |
Morgan Stanley
New York
|
+$129K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$38.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$61K |
| 2 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$37K |
| 3 |
GF
Gerstein Fisher
New York
|
-$27K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$17.3K |
| 5 |
ICAS
Investors Capital Advisory Services
Lynnfield,
Massachusetts
|
-$7.18K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HCM
1
Highlander Capital Management
Short Hills,
New Jersey
| $593K | +$422K | +19,567 | +96% |
|
|
AFM
2
Anson Funds Management
Dallas,
Texas
| $338K | +$494K | +22,879 | New |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $196K | +$286K | +13,246 | New |
|
|
4
Morgan Stanley
New York
| $126K | +$129K | +5,983 | +233% |
|
5
California Public Employees Retirement System
Sacramento,
California
| $62K | – | – | – |
|
|
VKH
6
Virtu KCG Holdings
New York
| $26K | +$38.5K | +1,784 | New |
|
|
ICAS
7
Investors Capital Advisory Services
Lynnfield,
Massachusetts
| $13K | -$7.18K | -333 | -27% |
|
8
UBS Group
Zurich,
Switzerland
| $6K | +$8.84K | +410 | +1,367% |
|
|
9
Group One Trading
Chicago,
Illinois
| $1K | -$17.3K | -800 | -91% |
|
10
Citigroup
New York
| $1K | -$647 | -30 | -26% |
|
11
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$61K | -2,054 | Closed |
|
|
RCM
13
Rotella Capital Management
Bellevue,
Washington
| – | -$37K | -1,245 | Closed |
|
|
GF
14
Gerstein Fisher
New York
| – | -$27K | -917 | Closed |
|
ROSG Hedge Fund Activity: Q4 2015 in Review
11 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Rosetta Genomics Ltd. (ROSG) for Q4 2015, worth a combined $1.36M — up 36% from $1M a quarter earlier.
Fund positioning in ROSG was balanced in Q4 2015: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 3 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $494K. The largest seller was Citadel Advisors, exiting entirely with an estimated $61K sold.
- 11 institutional investors held Rosetta Genomics Ltd. (ROSG) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $1.36M of Rosetta Genomics Ltd. stock for Q4 2015, up 36% quarter-over-quarter.
- 3 funds opened new Rosetta Genomics Ltd. positions in Q4 2015 and 3 closed out, a net change of 0 holders.
- The largest Rosetta Genomics Ltd. buyer in Q4 2015 was Anson Funds Management, an estimated $494K added.
- The largest Rosetta Genomics Ltd. seller in Q4 2015 was Citadel Advisors, an estimated $61K sold.
Based on aggregated 13F filings for Q4 2015.